IRIS Accounts Production v25.3.0.601 12032569 Board of Directors 1.7.24 30.6.25 30.6.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary C 1.00000 1.00000 551 624 147964 99749 147429 99676 16 551 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh120325692024-06-30120325692025-06-30120325692024-07-012025-06-30120325692023-06-30120325692023-07-012024-06-30120325692024-06-3012032569ns15:EnglandWales2024-07-012025-06-3012032569ns14:PoundSterling2024-07-012025-06-3012032569ns10:Director12024-07-012025-06-3012032569ns10:PrivateLimitedCompanyLtd2024-07-012025-06-3012032569ns10:SmallEntities2024-07-012025-06-3012032569ns10:AuditExempt-NoAccountantsReport2024-07-012025-06-3012032569ns10:SmallCompaniesRegimeForDirectorsReport2024-07-012025-06-3012032569ns10:SmallCompaniesRegimeForAccounts2024-07-012025-06-3012032569ns10:FullAccounts2024-07-012025-06-3012032569ns10:OrdinaryShareClass12024-07-012025-06-3012032569ns10:OrdinaryShareClass22024-07-012025-06-3012032569ns10:OrdinaryShareClass32024-07-012025-06-3012032569ns10:OrdinaryShareClass332024-07-012025-06-301203256942ns10:Director22024-06-301203256942ns10:Director22023-06-301203256942ns10:Director22024-07-012025-06-301203256942ns10:Director22023-07-012024-06-301203256942ns10:Director22025-06-301203256942ns10:Director22024-06-3012032569ns5:CurrentFinancialInstruments2025-06-3012032569ns5:CurrentFinancialInstruments2024-06-3012032569ns5:ShareCapital2025-06-3012032569ns5:ShareCapital2024-06-3012032569ns5:RetainedEarningsAccumulatedLosses2025-06-3012032569ns5:RetainedEarningsAccumulatedLosses2024-06-3012032569ns10:RegisteredOffice2024-07-012025-06-3012032569ns10:OrdinaryShareClass12025-06-3012032569ns10:OrdinaryShareClass22025-06-3012032569ns10:OrdinaryShareClass32025-06-3012032569ns10:Director22024-07-012025-06-3012032569ns10:Director112024-06-3012032569ns10:Director112023-06-3012032569ns10:Director112024-07-012025-06-3012032569ns10:Director112023-07-012024-06-3012032569ns10:Director112025-06-3012032569ns10:Director112024-06-30
REGISTERED NUMBER: 12032569 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2025

for

IQ Medicolegal Ltd

IQ Medicolegal Ltd (Registered number: 12032569)






Contents of the Financial Statements
for the Year Ended 30 June 2025




Page

Balance Sheet 1

Notes to the Financial Statements 2


IQ Medicolegal Ltd (Registered number: 12032569)

Balance Sheet
30 June 2025

30.6.25 30.6.24
Notes £    £   
CURRENT ASSETS
Debtors 4 2,916 4,475
Cash at bank 29,689 44,997
32,605 49,472
CREDITORS
Amounts falling due within one year 5 21,345 21,055
NET CURRENT ASSETS 11,260 28,417
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,260

28,417

CAPITAL AND RESERVES
Called up share capital 6 201 200
Retained earnings 11,059 28,217
SHAREHOLDERS' FUNDS 11,260 28,417

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 November 2025 and were signed on its behalf by:





Dr I Qurashi - Director


IQ Medicolegal Ltd (Registered number: 12032569)

Notes to the Financial Statements
for the Year Ended 30 June 2025

1. STATUTORY INFORMATION

IQ Medicolegal Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12032569

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 3 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.25 30.6.24
£    £   
Trade debtors 2,916 4,475

IQ Medicolegal Ltd (Registered number: 12032569)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2025

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.25 30.6.24
£    £   
Tax 19,749 19,184
Directors' current accounts 16 551
Accrued expenses 1,580 1,320
21,345 21,055

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.25 30.6.24
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
1 Ordinary C £1 1 -
(30.6.24 - NIL)
201 200

Allotted and issued:
Number: Class: Nominal 30.6.25 30.6.24
value: £    £   
1 Share capital 3 £1 1 -
(30.6.24 - NIL)

The following shares were issued during the year for cash at par :

1 Ordinary C share of £1

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 June 2025 and 30 June 2024:

30.6.25 30.6.24
£    £   
Dr I Qurashi and Mrs J Qurashi
Balance outstanding at start of year (551 ) (624 )
Amounts advanced 147,964 99,749
Amounts repaid (147,429 ) (99,676 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (16 ) (551 )

8. ULTIMATE CONTROLLING PARTY

The controlling party is the directors.